SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-136870
Filing Date
2013-04-01
Accepted
2013-04-01 17:08:58
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d511765d10qa.htm 10-Q/A 728478
2 EX-31.1 d511765dex311.htm EX-31.1 7503
3 EX-31.2 d511765dex312.htm EX-31.2 7735
4 EX-32.1 d511765dex321.htm EX-32.1 3740
5 EX-32.2 d511765dex322.htm EX-32.2 4362
  Complete submission text file 0001193125-13-136870.txt   10412461

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scln-20120630.xml EX-101.INS 2388804
7 XBRL TAXONOMY EXTENSION SCHEMA scln-20120630.xsd EX-101.SCH 41116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scln-20120630_cal.xml EX-101.CAL 48469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scln-20120630_def.xml EX-101.DEF 112303
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scln-20120630_lab.xml EX-101.LAB 284096
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scln-20120630_pre.xml EX-101.PRE 243342
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19825 | Film No.: 13732189
SIC: 2834 Pharmaceutical Preparations